» Articles » PMID: 32081981

X-ray Structure of LeuT in an Inward-facing Occluded Conformation Reveals Mechanism of Substrate Release

Abstract

Neurotransmitter:sodium symporters (NSS) are conserved from bacteria to man and serve as targets for drugs, including antidepressants and psychostimulants. Here we report the X-ray structure of the prokaryotic NSS member, LeuT, in a Na/substrate-bound, inward-facing occluded conformation. To obtain this structure, we were guided by findings from single-molecule fluorescence spectroscopy and molecular dynamics simulations indicating that L-Phe binding and mutation of the conserved N-terminal Trp8 to Ala both promote an inward-facing state. Compared to the outward-facing occluded conformation, our structure reveals a major tilting of the cytoplasmic end of transmembrane segment (TM) 5, which, together with release of the N-terminus but without coupled movement of TM1, opens a wide cavity towards the second Na binding site. The structure of this key intermediate in the LeuT transport cycle, in the context of other NSS structures, leads to the proposal of an intracellular release mechanism of substrate and ions in NSS proteins.

Citing Articles

Exploring the Structural Dynamics of LeuT Using EPR Spectroscopy: A Focus on Transmembrane Helix 10.

Tsalagradas P, Eke C, Andrews C, MacMillan F J Neurochem. 2025; 169(3):e70034.

PMID: 40052253 PMC: 11886772. DOI: 10.1111/jnc.70034.


Monitoring conformational changes in the human neurotransmitter transporter homologue LeuT with F-NMR spectroscopy.

Daminato A, Loland C, Cabrita E J Neurochem. 2024; 169(1):e16278.

PMID: 39680492 PMC: 11649037. DOI: 10.1111/jnc.16278.


The Role of Protonation in the PfMATE Transporter Protein Structural Transitions.

Hossen M, Bhattarai N, Chapagain P, Gerstman B Methods Mol Biol. 2024; 2870:315-340.

PMID: 39543042 DOI: 10.1007/978-1-0716-4213-9_16.


Alternating access of a bacterial homolog of neurotransmitter: sodium symporters determined from AlphaFold2 ensembles and DEER spectroscopy.

Schwartz A, Stein R, Gil-Iturbe E, Quick M, Mchaourab H Proc Natl Acad Sci U S A. 2024; 121(40):e2406063121.

PMID: 39302996 PMC: 11459141. DOI: 10.1073/pnas.2406063121.


Substrate binding and inhibition mechanism of norepinephrine transporter.

Ji W, Miao A, Liang K, Liu J, Qi Y, Zhou Y Nature. 2024; 633(8029):473-479.

PMID: 39143211 DOI: 10.1038/s41586-024-07810-5.


References
1.
Gether U, Andersen P, Larsson O, Schousboe A . Neurotransmitter transporters: molecular function of important drug targets. Trends Pharmacol Sci. 2006; 27(7):375-83. DOI: 10.1016/j.tips.2006.05.003. View

2.
Saier Jr M . A functional-phylogenetic classification system for transmembrane solute transporters. Microbiol Mol Biol Rev. 2000; 64(2):354-411. PMC: 98997. DOI: 10.1128/MMBR.64.2.354-411.2000. View

3.
Torres G, Amara S . Glutamate and monoamine transporters: new visions of form and function. Curr Opin Neurobiol. 2007; 17(3):304-12. DOI: 10.1016/j.conb.2007.05.002. View

4.
Kristensen A, Andersen J, Jorgensen T, Sorensen L, Eriksen J, Loland C . SLC6 neurotransmitter transporters: structure, function, and regulation. Pharmacol Rev. 2011; 63(3):585-640. DOI: 10.1124/pr.108.000869. View

5.
Jardetzky O . Simple allosteric model for membrane pumps. Nature. 1966; 211(5052):969-70. DOI: 10.1038/211969a0. View